西安地区11家三级医院2013-2015年辅助用药使用分析

发布时间：2018-06-28 10:19

本文选题：辅助用药 + 合理用药　；参考：《中国药房》2016年23期

【摘要】：目的:为促进临床合理用药及卫生行政部门制定用药政策提供依据。方法:对西安地区11家三级医院2013-2015年销售金额排名前20位的药品中辅助用药的总销售金额及构成比、单品种销售金额、用药频度(DDDs)、日均费用(DDC)等数据及不良反应情况进行统计分析。结果:西安地区11家三级医院2013-2015年辅助用药的总销售金额及构成比均呈上升趋势,3年间辅助用药销售金额构成比分别为8.43%、10.25%、12.20%。共有13种辅助用药至少1年进入3家以上医院药品总销售金额排名前20位;其中,小牛血清去蛋白注射液、前列地尔注射液和丹红注射液销售金额各年度均稳居前4位,注射用丹参多酚酸盐2014-2015年进入前3位;前列地尔注射液、血栓通注射和脾氨肽口服冻干粉各年度DDDs均居前3位;脾多肽注射液、注射用益气复脉和脑苷肌肽注射液DDC居前3位,分别为885.24、372.34和349.37元。辅助用药不良反应发生率逐年升高,由2013年的9.13%上升至2015年的13.49%。结论:辅助用药已成为西安地区医院临床用药的重要组成部分,其销售金额、用量增长较快。临床需要加强对辅助用药的管控,密切关注其安全性问题,控制医疗费用不合理增长。
[Abstract]:Objective: to provide the basis for the rational use of drugs in clinic and the formulation of drug use policy by health administration department. Methods: the total sales amount and composition ratio of auxiliary drugs in 11 tertiary hospitals in Xi'an from 2013 to 2015 were analyzed. DDDs, DDC and ADRs were statistically analyzed. Results: the total sales amount and composition ratio of supplementary drugs in 11 tertiary hospitals in Xi'an area showed an upward trend in 2013-2015. The proportion of total sales amount of supplementary drugs in Xi'an region in the past three years was 8.4310.25 and 12.20, respectively. A total of 13 kinds of adjuvant drugs entered at least one year into the top 20 of the total sales amount of drugs in 3 or more hospitals, among which, calf serum deproteinizing injection, alprostadil injection and Danhong injection were among the top 4 in each year. Salvia miltiorrhiza polyphenolic acid for injection came into the top 3 in 2014-2015, prostadil injection, Xue Tong injection and spleen aminopeptide oral lyophilized powder ranked first 3 in each year, spleen polypeptide injection, invigorating qi and supplementing pulse for injection and cerebral glycoside carnosine injection DDC ranked the top 3, It was 885.24372.34 and 349.37 yuan respectively. The incidence of ADRs increased from 9.13% in 2013 to 13.49% in 2015. Conclusion: adjuvant drug has become an important part of clinical use in Xi'an district hospital. It is necessary to strengthen the control of adjuvant drugs, pay close attention to its safety and control the unreasonable increase of medical expenses.
【作者单位】：西安市第四医院药剂科;
【分类号】：R969.3

【相似文献】